0002121301-26-000001.txt : 20260318 0002121301-26-000001.hdr.sgml : 20260318 20260318144509 ACCESSION NUMBER: 0002121301-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260318 DATE AS OF CHANGE: 20260318 EFFECTIVENESS DATE: 20260318 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nula Therapeutics, Inc. CENTRAL INDEX KEY: 0002121301 ORGANIZATION NAME: EIN: 872719092 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-576919 FILM NUMBER: 26768101 BUSINESS ADDRESS: STREET 1: 961 ARLINGTON AVE N CITY: ST. PETERSBURG STATE: FL ZIP: 33705 BUSINESS PHONE: 412-398-8046 MAIL ADDRESS: STREET 1: 961 ARLINGTON AVE N CITY: ST. PETERSBURG STATE: FL ZIP: 33705 D 1 primary_doc.xml X0708 D LIVE 0002121301 Nula Therapeutics, Inc. 961 Arlington Ave N St. Petersburg FL FLORIDA 33705 212-392-4735 DELAWARE Apollo Alpha, Inc. None Corporation true 2021 Christopher Shepard 961 Arlington Ave N St. Petersburg FL FLORIDA 33705 Executive Officer Director Jarod Rutledge 961 Arlington Ave N St. Petersburg FL FLORIDA 33705 Director Nils Regge 961 Arlington Ave N St. Petersburg FL FLORIDA 33705 Director Biotechnology Decline to Disclose 06b false 2026-02-17 false true true 0 7399003 7399003 0 false 7 0 0 0 false Nula Therapeutics, Inc. Christopher Shepard Christopher Shepard President 2026-03-18